|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||130.52 - 131.99|
|52-week range||130.52 - 131.99|
|Beta (5Y monthly)||0.54|
|PE ratio (TTM)||19.21|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Kimberly-Clark Corporation (NYSE: KMB) today announced that Robert Long has been named to the newly created role of Chief Research and Development Officer, effective March 15, 2021, with global responsibility for the company's research, development, innovation and quality functions. Long will report to Mike Hsu, Chairman and Chief Executive Officer, and serve on the company's executive leadership team.
As a brand committed to downtherecare, Cottonelle® announced today its partnership with BLKHLTH®, a nonprofit organization that seeks to reduce the impact of racism on Black health through education and action. In its inaugural year, Cottonelle has committed a $750,000 donation to BLKHLTH with programming aimed to reach Black people with critical information about colorectal cancer, commonly known as cancer of the colon or rectum. Colorectal cancer is the second leading cause of cancer related deaths among Americans, with Black Americans having a 40 percent higher death rate compared to White Americans. However, if caught and treated early, colorectal cancer has a 90 percent survival rate.
Readers hoping to buy Kimberly-Clark Corporation ( NYSE:KMB ) for its dividend will need to make their move shortly, as...